Thermo Fisher to acquire data intelligence company CorEvitas for $900M+
Thermo Fisher Scientific is set to acquire the data intelligence company CorEvitas for $912.5 million in cash.
CorEvitas, which is based near Thermo Fisher’s headquarters in Waltham, MA, specializes in real-world evidence generation. The company has 12 registries, including nine in the autoimmune and inflammatory spaces, and boasts more than 400 investigator sites with over 100,000 patients in its system.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.